首页 | 本学科首页   官方微博 | 高级检索  
     


Deficiency of GMDS Leads to Escape from NK Cell-Mediated Tumor Surveillance Through Modulation of TRAIL Signaling
Authors:Kenta Moriwaki  Katsuhisa Noda  Yoichi Furukawa  Kenji Ohshima  Airi Uchiyama  Tsutomu Nakagawa  Naoyuki Taniguchi  Yataro Daigo  Yusuke Nakamura  Norio Hayashi  Eiji Miyoshi
Affiliation:3. Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan;4. Division of Clinical Genome Research, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan;5. Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, Center for Advanced Science and Innovation, Osaka, Japan;1. i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen, 4200-135 Porto, Portugal;2. Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Júlio Amaral de Carvalho 45, 4200-465 Porto, Portugal;3. Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira, 4050-313 Porto, Portugal;4. Medical Faculty, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal;1. Cancer Biomarkers Development Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon, South Korea;2. Department of Surgery, College of Medicine, The Catholic University of Korea, Inchon 403-720, South Korea;1. Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan;2. Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan;3. Genome Science Division, RCAST, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan;1. I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal;2. Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal;3. Cellular and Molecular Oncobiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro 20231-050, Brazil;4. Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal;5. Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal;1. Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA;2. Birmingham VA Medical Center, Birmingham, AL 35294, USA;3. Therapeutic Discovery, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA;1. Department of Pathology, Case Western Reserve University, Cleveland, Ohio;7. Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio;8. Institute for Computational Biology, Case Western Reserve University, Cleveland, Ohio;12. Department of Medicine, Case Western Reserve University, Cleveland, Ohio;2. Department of Biomedical Engineering, Cornell University, Ithaca, New York;3. Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio;6. Department of Internal Medicine, University Hospitals Case Medical Center, Cleveland, Ohio;4. Life Sciences Institute, University of Michigan, Ann Arbor, Michigan;5. School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania;9. Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts;10. Department of Chemistry, Cleveland State University, Cleveland, Ohio;11. Department of Colorectal Surgery, Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio;13. Department of Pathology, Genentech, Inc, San Francisco, California
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号